Treatment of a multiple sclerosis animal model by a novel nanodrop formulation of a natural antioxidant

被引:50
作者
Binyamin, Orli [1 ]
Larush, Liraz [2 ]
Frid, Kati [1 ]
Keller, Guy [1 ]
Friedman-Levi, Yael [1 ]
Ovadia, Haim [1 ]
Abramsky, Oded [1 ]
Magdassi, Shlomo [2 ]
Gabizon, Ruth [1 ]
机构
[1] Hadassah Univ Hosp, Dept Neurol, Agnes Ginges Ctr Human Neurogenet, IL-91120 Jerusalem, Israel
[2] Hebrew Univ Jerusalem, Casali Inst Chem, Jerusalem, Israel
关键词
nanodrops; PSO; EAE; oxidative stress; neurodegeneration; SOLID LIPID NANOPARTICLES; POMEGRANATE SEED OIL; OXIDATIVE STRESS; NEURODEGENERATIVE DISEASES; MOLECULAR-MECHANISMS; LINOLEIC-ACID; BRAIN; PEROXIDATION; MICE; LIPOPROTEINS;
D O I
10.2147/IJN.S92704
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system and is associated with demyelination, neurodegeneration, and sensitivity to oxidative stress. In this work, we administered a nanodroplet formulation of pomegranate seed oil (PSO), denominated Nano-PSO, to mice induced for experimental autoimmune encephalomyelitis (EAE), an established model of MS. PSO comprises high levels of punicic acid, a unique polyunsaturated fatty acid considered as one of the strongest natural antioxidants. We show here that while EAE-induced mice treated with natural PSO presented some reduction in disease burden, this beneficial effect increased significantly when EAE mice were treated with Nano-PSO of specific size nanodroplets at much lower concentrations of the oil. Pathological examinations revealed that Nano-PSO administration dramatically reduced demyelination and oxidation of lipids in the brains of the affected animals, which are hallmarks of this severe neurological disease. We propose that novel formulations of natural antioxidants such as Nano-PSO may be considered for the treatment of patients suffering from demyelinating diseases. On the mechanistic side, our results demonstrate that lipid oxidation may be a seminal feature in both demyelination and neurodegeneration.
引用
收藏
页码:7165 / 7174
页数:10
相关论文
共 52 条
[21]   Curcumin: From ancient medicine to current clinical trials [J].
Hatcher, H. ;
Planalp, R. ;
Cho, J. ;
Tortia, F. M. ;
Torti, S. V. .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2008, 65 (11) :1631-1652
[22]   Neurodegeneration in autoimmune CNS inflammation [J].
Herz, Josephine ;
Zipp, Frauke ;
Siffrin, Volker .
EXPERIMENTAL NEUROLOGY, 2010, 225 (01) :9-17
[23]   In vivo pharmacokinetics and biodistribution of resveratrol-loaded solid lipid nanoparticles for brain delivery [J].
Jose, S. ;
Anju, S. S. ;
Cinu, T. A. ;
Aleykutty, N. A. ;
Thomas, S. ;
Souto, E. B. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2014, 474 (1-2) :6-13
[24]   Markers of oxidative stress in plasma and saliva in patients with multiple sclerosis [J].
Karlik, Martin ;
Valkovic, Peter ;
Hancinova, Viera ;
Krizova, Lucia ;
Tothova, Lubomira ;
Celec, Peter .
CLINICAL BIOCHEMISTRY, 2015, 48 (1-2) :24-28
[25]   Pomegranate oil analysis with emphasis on MALDI-TOF/MS triacylglycerol fingerprinting [J].
Kaufman, Maya ;
Wiesman, Zeev .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2007, 55 (25) :10405-10413
[26]   Bioavailability of nanoemulsified conjugated linoleic acid for an antiobesity effect [J].
Kim, Dongyeop ;
Park, Jin-Hong ;
Kweon, Dae-Jun ;
Han, Gi Dong .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2013, 8 :451-459
[27]   Pegylated nanoliposomes remote-loaded with the antioxidant tempamine ameliorate experimental autoimmune encephalomyelitis [J].
Kizelsztein, Pablo ;
Ovadia, Haim ;
Garbuzenko, Olga ;
Sigal, Alex ;
Barenholz, Yechezkel .
JOURNAL OF NEUROIMMUNOLOGY, 2009, 213 (1-2) :20-25
[28]  
Kong W, 2013, BRAIN BEHAV IMMUN, V25, P872
[29]   Mechanisms of inflammation induced tissue injury in multiple sclerosis [J].
Lassmann, Hans .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2008, 274 (1-2) :45-47
[30]  
Leitinger Norbert, 2008, V49, P325, DOI 10.1007/978-1-4020-8830-8_12